Exhibit 107
Calculation of Filing Fee Tables
F-3
(Form Type)
Evaxion Biotech A/S
(Exact Name of Registrant as Specified in its Charter)
N/A
(Translation of Registrant’s Name into English)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Ordinary Shares DKK1 nominal value (1) | 457(o) | (2 | ) | (3 | ) | $ | 100,000,000 | $ | .0000927 | $ | 9,270 | (4) | ||||||||||||||||||||||||||||||
| Fees Previously Paid | _ | _ | _ | _ | _ | _ | _ | |||||||||||||||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
| Total Offering Amounts | $ | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||||
| Total Fees Previously Paid | _N/A | |||||||||||||||||||||||||||||||||||||||||||
| Total Fee Offsets | _N/A | |||||||||||||||||||||||||||||||||||||||||||
| Net Fee Due | $ | 9,270 | ||||||||||||||||||||||||||||||||||||||||||
| (1) | The ordinary shares registered hereby will be represented by the registrant’s American Depositary Shares (“ADSs”), each of which will represent one (1) ordinary share of the registrant. Such ADSs issuable on deposit of the ordinary shares registered hereby have been registered under a separate registration statements on Form F-6 (File No.: 333-252038). |
| (2) | There are being registered hereunder such indeterminate number of ordinary shares as may from time to time be offered hereunder at indeterminate prices, in U.S. dollars or the equivalent thereof denominated in foreign currencies, as shall have aggregate initial offering price not to exceed $100,000,000. Pursuant to Rule 416 under the Securities Act, this registration statement also covers any additional ordinary shares that may be offered or issued in connection with any share split, share dividend or similar transactions. |
| (3) | The proposed maximum offering price per ordinary share will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified pursuant to General Instruction II.C. of Form F-3 under the Securities Act. |
| (4) | The maximum aggregate offering price reflected in the table has been estimated solely for purposes of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
